Sublingual Semaglutide is placed under the tongue, where it is absorbed through oral tissues. It interacts with GLP-1 pathways, which play a role in appetite, satiety, and eating behavior. Because this is a compounded version, absorption may differ from injectable GLP-1 medications, and effects vary widely between individuals.

It is used as part of lifestyle-based wellness programs that include nutrition, hydration, movement, and consistent habits.

No. Only the injectable versions of semaglutide (such as Wegovy® and Ozempic®) are FDA-approved. Sublingual semaglutide is a compounded formulation prepared by licensed pharmacies based on a prescriber’s order. It is not approved to diagnose, treat, or cure any condition.

Responses vary significantly because sublingual formulations may absorb differently than injectables. Some individuals report appetite-related support, while others may experience minimal effects.

Important factors include:

• Consistency of daily dosing
• Nutrition and hydration habits
• Sleep and stress levels
• Individual metabolic differences

Your provider will help set realistic expectations based on your goals.

Some individuals report early appetite-regulation benefits within 2–4 weeks, while others may require 6–8 weeks of consistent use. Compounded sublingual formulations may take longer due to differences in absorption.

No specific outcome or timeline can be guaranteed.

Possible side effects may include:

• Mild nausea
• Digestive discomfort
• Headache
• Changes in appetite

More significant side effects are rare but possible. Contact your provider immediately if you experience severe stomach pain, allergic symptoms, or difficulty swallowing or breathing.

You should avoid compounded semaglutide unless approved by a provider if you:

• Are pregnant or breastfeeding
• Have a history of pancreatitis
• Have severe gastrointestinal disorders
• Have personal or family history of certain thyroid tumors
• Use other GLP-1 medications

Your provider will review your medical history to determine eligibility.

Some individuals prefer sublingual drops due to needle sensitivity or convenience. However, the two forms are not equivalent in absorption or dosing. Your provider will determine whether switching is appropriate and safe.

Many individuals combine sublingual semaglutide with:

• Wellness peptides
• MIC/B12 or Lipo-C injections
• Vitamin or metabolic support protocols
• NAD+ programs

Your clinician will review your medications and supplements to ensure safety and compatibility.

Most protocols require placing the drops under the tongue and holding them for 60–90 seconds before swallowing. This helps support sublingual absorption. Avoid eating or drinking immediately afterward unless directed by your provider.

The process is simple and provider-guided:

• Step 1: Complete the online intake.
• Step 2: Meet with a licensed clinician.
• Step 3: If appropriate, your prescription is sent to a partner compounding pharmacy.
• Step 4: Your Sublingual Semaglutide drops ship directly to your door.

Your provider will guide dosing and check-ins as needed.